In8Bio (INAB) Return on Capital Employed [ROCE] (2021 - 2026)
In8Bio (INAB) reported Return on Capital Employed [ROCE] of -85.82% for Q2 2026, up 49.41 percentage points from -135.23% a year earlier but down 15.82 percentage points from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends
For FY2025, In8Bio posted Return on Capital Employed [ROCE] of -82.89%, up 42.65 percentage points from FY2024.
- Return on Capital Employed [ROCE] has a four-year change of -32.90 percentage points (FY2021 to FY2025).
- By year, Return on Capital Employed [ROCE] came in at -125.55% in FY2024 (-18.31 pp), -107.24% in FY2023 (-17.58 pp), -89.66% in FY2022 (-39.67 pp) and -49.99% in FY2021.
- Five-year quarterly Return on Capital Employed [ROCE] spans a low of -204.38% in Q3 2024 and a high of -34.54% in Q4 2021.
- Year over year, Return on Capital Employed [ROCE] has now increased in each of the last four quarters, with an average year-over-year change of +28.55 percentage points over the last six quarters.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q4 2025 (a gain of 107.01 percentage points); the low point was Q4 2024 (a drop of 75.85 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -70.00% (Q1 2026), -90.99% (Q4 2025) and -126.22% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.86% |
| 10 | In8Bio | 20.44 Mn | -57.91 Mn | - | -85.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -85.82% |
| Mar 31, 2026 | -70.00% |
| Dec 31, 2025 | -90.99% |
| Sep 30, 2025 | -126.22% |
| Jun 30, 2025 | -135.23% |
| Mar 31, 2025 | -157.17% |
| Dec 31, 2024 | -198.00% |
| Sep 30, 2024 | -204.38% |
| Dec 31, 2023 | -122.15% |
| Sep 30, 2023 | -129.77% |
| Jun 30, 2023 | -129.98% |
| Mar 31, 2023 | -119.08% |
| Dec 31, 2022 | -95.42% |
| Sep 30, 2022 | -89.21% |
| Jun 30, 2022 | -73.28% |
| Mar 31, 2022 | -49.41% |
| Dec 31, 2021 | -34.54% |
| Sep 30, 2021 | -36.82% |
API Access
In8Bio Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();